Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine
Current formulations of GLP-1 analogs rely primarily on subcutaneous injections, which may pose challenges to patient convenience and long-term adherence
Sustain results after GLP-1s with Virtas nutrition therapy that addresses the root cause of obesity and unhealthy weight A proven approach for deprescribing GLP-1s when clinically appropriate Our first of its kind research study shows sustained weight loss after deprescribing GLP-1s among a real world population
As GLP-1 RAs are contraindicated for people with gastrointestinal disease, pancreatitis, or a family history of mutations in multiple endocrine neoplasia type 2/medullary thyroid carcinoma (MEN2/MTC), SGLT2i is the preferred treatment for these patients groups
PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights, including key variants like GIPR rs1800437 and FTO rs9939609, and MC4R rs17782313 that directly influence how your body responds to semaglutide
